Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monia Marchetti

Showing results (71-80 of 123) with videos related to

Pageof 13
Sort By:
Leukemia & Lymphoma|March 5, 2003
Thalidomide in myelofibrosis with myeloid metaplasia: a pooled-analysis of individual patient data from five studiesGiovanni Barosi, Barosi Giovanni, Michelle Elliott, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 31, 2004
Low-dose thalidomide ameliorates cytopenias and splenomegaly in myelofibrosis with myeloid metaplasia: a phase II trialMonia Marchetti, Giovanni Barosi, Francesca Balestri, et al.
Hematological Oncology|August 6, 2022
Lack of efficacy of convalescent plasma in COVID-19 patients with concomitant hematological malignancies: An Italian retrospective studyFrancesco Lanza, Federica Monaco, Fabio Ciceri, et al.
The European Respiratory Journal|March 14, 2024
ERS/EBMT clinical practice guidelines on treatment of pulmonary chronic graft-<i>versus</i>-host disease in adultsSaskia Bos, John Murray, Monia Marchetti, et al.
The Lancet. Haematology|January 6, 2024
Prophylaxis and management of graft-versus-host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow TransplantationOlaf Penack, Monia Marchetti, Mahmoud Aljurf, et al.
Leukemia|March 9, 2018
Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNetTiziano Barbui, Ayalew Tefferi, Alessandro M Vannucchi, et al.
British Journal of Haematology|December 21, 2022
SARS-CoV-2 infection and vaccination in patients with hairy-cell leukaemiaEnrico Tiacci, Alessandro Mancini, Monia Marchetti, et al.
Intensive Care Medicine|October 10, 2013
A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational expertsMatteo Bassetti, Monia Marchetti, Arunaloke Chakrabarti, et al.
The Lancet. Haematology|February 1, 2020
Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow TransplantationOlaf Penack, Monia Marchetti, Tapani Ruutu, et al.
Blood Advances|February 27, 2026
Phase 2 study of the lysine-specific demethylase 1 (LSD1) inhibitor bomedemstat for essential thrombocythemiaHarinder Gill, Francesca Palandri, David M Ross, et al.
Pageof 13

Showing results (71-80 of 123) with videos related to

Sort By:
Pageof 13
Leukemia & Lymphoma|March 5, 2003
Thalidomide in myelofibrosis with myeloid metaplasia: a pooled-analysis of individual patient data from five studiesGiovanni Barosi, Barosi Giovanni, Michelle Elliott, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 31, 2004
Low-dose thalidomide ameliorates cytopenias and splenomegaly in myelofibrosis with myeloid metaplasia: a phase II trialMonia Marchetti, Giovanni Barosi, Francesca Balestri, et al.
Hematological Oncology|August 6, 2022
Lack of efficacy of convalescent plasma in COVID-19 patients with concomitant hematological malignancies: An Italian retrospective studyFrancesco Lanza, Federica Monaco, Fabio Ciceri, et al.
The European Respiratory Journal|March 14, 2024
ERS/EBMT clinical practice guidelines on treatment of pulmonary chronic graft-<i>versus</i>-host disease in adultsSaskia Bos, John Murray, Monia Marchetti, et al.
The Lancet. Haematology|January 6, 2024
Prophylaxis and management of graft-versus-host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow TransplantationOlaf Penack, Monia Marchetti, Mahmoud Aljurf, et al.
Leukemia|March 9, 2018
Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNetTiziano Barbui, Ayalew Tefferi, Alessandro M Vannucchi, et al.
British Journal of Haematology|December 21, 2022
SARS-CoV-2 infection and vaccination in patients with hairy-cell leukaemiaEnrico Tiacci, Alessandro Mancini, Monia Marchetti, et al.
Intensive Care Medicine|October 10, 2013
A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational expertsMatteo Bassetti, Monia Marchetti, Arunaloke Chakrabarti, et al.
The Lancet. Haematology|February 1, 2020
Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow TransplantationOlaf Penack, Monia Marchetti, Tapani Ruutu, et al.
Blood Advances|February 27, 2026
Phase 2 study of the lysine-specific demethylase 1 (LSD1) inhibitor bomedemstat for essential thrombocythemiaHarinder Gill, Francesca Palandri, David M Ross, et al.
Pageof 13